Drug Pipeline

Certolizumab Pegol Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04123795 A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol… Moderate Chronic Plaque Psoriasis Active, Not Recruiting
Phase 2
NCT03152058 IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy High Risk Pregnancy Recruiting
Not specified
NCT07491913 Biologic Treatment Withdrawal in Takayasu Arteritis Patients in Sustained Remission Takayasu Arteritis Recruiting
Sponsors Running Certolizumab Pegol Trials
David Ware Branch (1) UCB Biopharma SRL (1) Marmara University (1)
Disease Areas
Lupus (SLE) (1) Psoriasis (1)
Get alerts when Certolizumab Pegol trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free